PharmiWeb

Global Reverse Transcriptase Enzymes Industry is estimated to reach US$ 481.8 Million by 2032, growing at a 3.4% CAGR | FMI

The global reverse transcriptase enzymes industry has witnessed remarkable growth and is anticipated to further expand, reaching a valuation of US$ 335.0 Million in 2022 and projected to escalate to ...
PharmiWeb

Reverse Transcriptase Enzymes Market is expected to account for US$ 481.8 Million, at a CAGR of 3.4% through 2032

The Reverse Transcriptase Enzymes Market is expected to reach US$ 335.0 Million in 2022. By 2032, the market for reverse transcriptase enzymes is anticipated to reach US$ 481.8 Million with a CAGR of ...
The Hindu

The bacteria that write new genes to cope with infections

Amid the unprecedented challenges presented by the COVID-19 pandemic, a once obscure enzyme found itself in the spotlight: reverse transcriptase. As laboratories worldwide rushed to develop reliable ...
The Scientist

Thermostable Reverse Transcriptase at Room Temperature

New England Biolabs (NEB®) announced today that they have released a novel, thermostable reverse transcriptase, WarmStart® RTx Reverse Transcriptase, specifically designed for nucleic acid detection.